atosiban and its Impurities

Atosiban is used intravenously to halt premature labor.It is an inhibitor of the hormones oxytocin and vasopressin. Reference standards of Atosiban API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 11 results for atosiban Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 28 37000

Atosiban

Atosiban


  • Catalogue No.:PA 28 37000

  • CAS :

    90779-69-4

  • Molecular Formula : C43H67N11O12S2

  • Molecular Weight : 994.19

Drug Reference Standards & Impurity Synthesis in India
PA 28 37510

Atosiban Acetate

Atosiban Acetate


  • Catalogue No.:PA 28 37510

  • CAS :

    914453-95-5

  • Molecular Formula : C45H71N11O14S2

  • Molecular Weight : 1054.24

Drug Reference Standards & Impurity Synthesis in India
PA 28 37520

(S)-N-((S)-5-Amino-1-((2-((hydroxymethyl)amino)-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide compound with ethane (1:1)

(S)-N-((S)-5-Amino-1-((2-((hydroxymethyl)amino)-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide compound with ethane (1:1)


  • Catalogue No.:PA 28 37520

  • CAS :

    NA

  • Molecular Formula : C46H75N11O13S2

  • Molecular Weight : 1054.28

Drug Reference Standards & Impurity Synthesis in India
PA 28 37530

(S)-N-((S)-5-Amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-7-(2-((hydroxymethyl)amino)-2-oxoethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide

(S)-N-((S)-5-Amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-7-(2-((hydroxymethyl)amino)-2-oxoethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide


  • Catalogue No.:PA 28 37530

  • CAS :

    NA

  • Molecular Formula : C44H69N11O13S2

  • Molecular Weight : 1024.21

Drug Reference Standards & Impurity Synthesis in India
PA 28 0371000

(S)-1-((4R,7S,10S,13S,16R)-7-(2-Amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-N-((S)-2-oxopiperidin-3-yl)pyrrolidine-2-carboxamide

(S)-1-((4R,7S,10S,13S,16R)-7-(2-Amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-N-((S)-2-oxopiperidin-3-yl)pyrrolidine-2-carboxamide


  • Catalogue No.:PA 28 0371000

  • CAS :

    NA

  • Molecular Formula : C41H61N9O11S2

  • Molecular Weight : 920.11

Drug Reference Standards & Impurity Synthesis in India
PA 28 0371001

(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)Methyl)-10-(4-aminobutyl)-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-19-((R)-2-((E)-6-hydrazono-1,6-dihydropyridine-3-carboxamido)-3-phenylpropanamido)-16-(4-hydroxybenzyl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide

(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)Methyl)-10-(4-aminobutyl)-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-19-((R)-2-((E)-6-hydrazono-1,6-dihydropyridine-3-carboxamido)-3-phenylpropanamido)-16-(4-hydroxybenzyl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide


  • Catalogue No.:PA 28 0371001

  • CAS :

    257943-19-4

  • Molecular Formula : C55H71N13O12S2

  • Molecular Weight : 1170.37

Drug Reference Standards & Impurity Synthesis in India
PA 28 0371002

(2S)-N1-((2R)-1-((2S)-2-((5-Amino-1-((2-Amino-2-oxoethyl)amino)-1-Oxopentan-2-yl)Carbamoyl)pyrrolidin-1-yl)-3-Mercapto-1-oxopropan-2-yl)-2-((2S,3R)-2-((2S,3S)-2-((R)-3-(4-Ethoxyphenyl)-2-(3-Mercaptopropanamido)Propanamido)-3-Methylpentanamido)-3-Hydroxybutanamido)Succinamide

(2S)-N1-((2R)-1-((2S)-2-((5-Amino-1-((2-Amino-2-oxoethyl)amino)-1-Oxopentan-2-yl)Carbamoyl)pyrrolidin-1-yl)-3-Mercapto-1-oxopropan-2-yl)-2-((2S,3R)-2-((2S,3S)-2-((R)-3-(4-Ethoxyphenyl)-2-(3-Mercaptopropanamido)Propanamido)-3-Methylpentanamido)-3-Hydroxybutanamido)Succinamide


  • Catalogue No.:PA 28 0371002

  • CAS :

    960411-86-3

  • Molecular Formula : C43H69N11O12S2

  • Molecular Weight : 996.21

Drug Reference Standards & Impurity Synthesis in India
PA 28 0371004

Atosiban 1-8 Lactam Impurity

Atosiban 1-8 Lactam Impurity


  • Catalogue No.:PA 28 0371004

  • CAS :

    NA

  • Molecular Formula : C41H61N9O11S2

  • Molecular Weight : 920.11

Drug Reference Standards & Impurity Synthesis in India
PA 28 0371005

((S)-5-Amino-2-((S)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamido)pentanoyl)glycine compound with 2,2,2-Trifluoroacetic Acid (1:1)

((S)-5-Amino-2-((S)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamido)pentanoyl)glycine compound with 2,2,2-Trifluoroacetic Acid (1:1)


  • Catalogue No.:PA 28 0371005

  • CAS :

    NA

  • Molecular Formula : C45H67F3N10O15S2

  • Molecular Weight : 1109.2

Drug Reference Standards & Impurity Synthesis in India
PA PEP 001822

[Gly9-OH]-Atosiban

[Gly9-OH]-Atosiban


  • Catalogue No.:PA PEP 001822

  • CAS :

    168102-69-0

  • Molecular Formula : C43H66N10O13S2

  • Molecular Weight : 995.18

Drug Reference Standards & Impurity Synthesis in India
PA 28 0371006

tert-Butyl (S)-4-((S)-sec-butyl)-2,5-dioxooxazolidine-3-carboxylate

tert-Butyl (S)-4-((S)-sec-butyl)-2,5-dioxooxazolidine-3-carboxylate


  • Catalogue No.:PA 28 0371006

  • CAS :

    145929-76-6

  • Molecular Formula : C12H19NO5

  • Molecular Weight : 257.29

pharmaffiliates